Our Company

Hememics Biotechnologies is transforming the future of antibody screening with breakthrough monolayer graphene technology. Our innovative reader and Fast Antibody Survey Technology (FAST™) multiplexed chips precisely assess antibody-antigen binding in less than an hour.

FAST™ platform features cost-effective, polymer based, disposable chips, eliminating the need for expensive equipment and costly consumables. With FAST™, we are combining speed, accuracy, affordability, and ease of use, thus redefining what is possible in antibody testing - improving biologics and basic research productivity. 

​